| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2–, Node-Positive, High-Risk Early Breast Cancer
|
Davie, Alison
|
|
|
42 |
6 |
p. 2767-2781
|
artikel
|
| 2 |
Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study
|
Evans, Marc
|
|
|
42 |
6 |
p. 2821-2832
|
artikel
|
| 3 |
An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy
|
Glassock, Richard J.
|
|
|
42 |
6 |
p. 2545-2558
|
artikel
|
| 4 |
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects
|
Xu, Jia
|
|
|
42 |
6 |
p. 2797-2807
|
artikel
|
| 5 |
Assessment of Access Barriers to Rifaximin Among Patients with Hepatic Encephalopathy Using Adjudicated Claims Data
|
Jesudian, Arun
|
|
|
42 |
6 |
p. 2739-2753
|
artikel
|
| 6 |
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study
|
Augustin, Matthias
|
|
|
42 |
6 |
p. 2728-2738
|
artikel
|
| 7 |
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
|
Wiland, Piotr
|
|
|
42 |
6 |
p. 2970-2971
|
artikel
|
| 8 |
Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies
|
Igarashi, Ataru
|
|
|
42 |
6 |
p. 2888-2905
|
artikel
|
| 9 |
Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy
|
Miyano, Kanako
|
|
|
42 |
6 |
p. 2833-2852
|
artikel
|
| 10 |
Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China
|
Chen, Junfeng
|
|
|
42 |
6 |
p. 2639-2658
|
artikel
|
| 11 |
Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments
|
Islam, Kazi
|
|
|
42 |
6 |
p. 2659-2678
|
artikel
|
| 12 |
Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma
|
Panettieri, Reynold A.
|
|
|
42 |
6 |
p. 2679-2689
|
artikel
|
| 13 |
Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens
|
Santoni, Aislinn
|
|
|
42 |
6 |
p. 2569-2586
|
artikel
|
| 14 |
Improving Clinical Management and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis in China via Real-world Evidence (IMPROVE Study): A Multicenter Prospective Cohort Study
|
Jiang, Nan
|
|
|
42 |
6 |
p. 2906-2921
|
artikel
|
| 15 |
Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United States
|
Geissbühler, Yvonne
|
|
|
42 |
6 |
p. 2808-2820
|
artikel
|
| 16 |
Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis
|
Deng, Lijuan
|
|
|
42 |
6 |
p. 2937-2949
|
artikel
|
| 17 |
LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area
|
Zhao, Liming
|
|
|
42 |
6 |
p. 2874-2887
|
artikel
|
| 18 |
Lidocaine—A Promising Candidate for the Treatment of Cancer-Induced Bone Pain: A Narrative Review
|
Luo, Lihan
|
|
|
42 |
6 |
p. 2587-2605
|
artikel
|
| 19 |
Long-Term Efficacy and Safety of Growth Hormone in Children Suffering from Short Stature in China (CGLS): An Open-Label, Multicenter, Prospective and Retrospective, Observational Study
|
Wu, Wei
|
|
|
42 |
6 |
p. 2957-2969
|
artikel
|
| 20 |
One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn’s Disease: A Network Meta-Analysis
|
Disher, Tim
|
|
|
42 |
6 |
p. 2708-2727
|
artikel
|
| 21 |
Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison
|
Dzienis, Marcin
|
|
|
42 |
6 |
p. 2690-2707
|
artikel
|
| 22 |
Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone Deficiency
|
Hoffman, Andrew R.
|
|
|
42 |
6 |
p. 2853-2873
|
artikel
|
| 23 |
Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer
|
Shah, Manasee V.
|
|
|
42 |
6 |
p. 2782-2796
|
artikel
|
| 24 |
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment
|
Rognoni, Carla
|
|
|
42 |
6 |
p. 2606-2638
|
artikel
|
| 25 |
The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 Study
|
Weber, Michel
|
|
|
42 |
6 |
p. 2922-2936
|
artikel
|
| 26 |
The Limitations of Artificial Intelligence in Head and Neck Oncology
|
Rao, Karthik N.
|
|
|
42 |
6 |
p. 2559-2568
|
artikel
|
| 27 |
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity
|
Kaplan, Alan
|
|
|
42 |
6 |
p. 2950-2956
|
artikel
|
| 28 |
Validation of an Administrative Claims-based Line of Therapy Algorithm for Women with Ovarian Cancer Using Medical Chart Review
|
Simmons, Daniel
|
|
|
42 |
6 |
p. 2754-2766
|
artikel
|
Tijdschrift beschrijving